{
  "id": "cluster_9_doc1",
  "content": "The latest policy revision (TT-449K) for complex rheumatology cases now requires pre-authorization for biosimilar medications. Sunset Hills Regional Clinic reported a 38% increase in claims denials during Q3 2023, with most cases involving patients who received infliximab infusions. Dr. Elaine Martinson's research team published findings linking delayed treatment initiation to poorer outcomes in seronegative arthritis patients aged 45-65.",
  "metadata": {
    "format": "policy_document"
  }
}